Stephen A. Sonstein, PhD, Chair of the CAAHEP’s Committee on Accreditation of Academic Programs in Clinical Research

New Standards for Accreditation Advance Professionalization of Clinical Research

Clinical research is taking another step toward professionalization with the anticipated approval  of new “Standards and Guidelines for the Accreditation of Academic Programs in Clinical Research” by the Commission on Accreditation of Allied Health Education Programs (CAAHEP), says Stephen A. Sonstein, PhD, professor and director of clinical research administration at Eastern Michigan University. Sonstein is […]

Debi Willis, CEO and Founder, PatientLink

PatientLink Captures ONC Challenge with Patient-Focused Data Platform

PatientLink, a software company based in Oklahoma City, Okla., has won first place in Phase 2 of the Office of the National Coordinator for Health Information Technology (ONC) Consumer Health Data Aggregator challenge. ONC is part of the U.S. Department of Health and Human Services. The competition was designed to inspire the development of third-party, […]

White House

Could Trump’s Pressure On Drug Prices, Regulations Impact Clinical Trials?

Whether you agree with the substance or not, there’s no denying that President Trump’s recent actions on immigration have seriously shaken things up at the Justice Department. Now it might be time for the clinical trial industry to pay closer attention. This week, Trump sent signals he has similar goals in his approach to the […]

Karen Dziadziola, RN, CCRC, Clinical Research Manager, Carolina Clinical Trials, LLC

Education: Your Key to Career Advancement

Editor’s Note: This post is a preview of what you’ll find in the February 2017 issue of Clinical Researcher, which provides key insights on the value of education and training to your career in clinical research. Education fuels personal and professional growth. Whether you are at the beginning of your career, already established, or even […]

Biosafety Blog Image

Emphasis on Biosafety in Trials on the Rise

U.S. Food and Drug Administration–approved gene therapies have long been an elusive goal for medical science. However, “the climate is right for advances in clinical trials involving human gene transfer, particularly for oncology research,” says Daniel Eisenman, PhD, RBP, SM(NRCM), CBSP, Biosafety Officer at Schulman IRB. Such clinical trials involve the deliberate transfer of engineered […]